Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (unaudited)

v3.19.3
Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Statement of Comprehensive Income [Abstract]        
Revenue $ 3 $ 8 $ 38
Cost of revenue 62 65 56
Gross loss (59) (57) (18)
Operating expenses:        
Research and development 2,173 1,770 6,706 4,357
Sales and marketing 1,160 1,215 3,473 2,945
General and administrative 2,028 2,145 7,189 6,021
Total operating expenses 5,361 5,130 17,368 13,323
Operating loss (5,420) (5,130) (17,425) (13,341)
Warrant expense (3,156)
Gain (loss) on change in estimated fair value of contingent royalty obligation 127 (85) 68 (244)
Finance income, net 95 44 214 73
Foreign currency gain (loss) 3 1 (6) (22)
Loss before income taxes (5,195) (5,170) (17,149) (16,690)
Income tax expense
Net loss $ (5,195) $ (5,170) $ (17,149) $ (16,690)
Basic and diluted loss per common share (in dollars per share) $ (0.18) $ (0.33) $ (0.72) $ (1.13)
Weighted average number of common shares outstanding, basic and diluted (in shares) 28,716,213 15,680,750 23,896,843 14,782,285